Panorama test (by Natera)

The Panorama test by Natera is a non-invasive prenatal screening that analyzes cell-free DNA from a pregnant woman's blood to assess the risk of certain chromosomal conditions in the fetus, such as Down syndrome (trisomy 21) and other aneuploidies. It offers early detection (usually from 10 weeks of pregnancy) without the need for invasive procedures like amniocentesis. While it provides risk estimates rather than a definitive diagnosis, its high accuracy helps expectant parents and healthcare providers make informed decisions about further testing or planning.